Co-Authors
This is a "connection" page, showing publications co-authored by Mary Ramsay and Shamez Ladhani.
Connection Strength
8.420
-
Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England. J Infect. 2021 11; 83(5):573-580.
Score: 0.962
-
SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020. EClinicalMedicine. 2021 Jul; 37:100948.
Score: 0.950
-
SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study. Lancet Child Adolesc Health. 2021 06; 5(6):417-427.
Score: 0.935
-
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. Lancet Infect Dis. 2018 04; 18(4):441-451.
Score: 0.752
-
Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study. PLoS One. 2021; 16(8):e0255517.
Score: 0.241
-
Secondary Attack Rate and Family Clustering of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children of Healthcare Workers With Confirmed Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 07 01; 73(1):e260-e263.
Score: 0.238
-
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Primary School Age Children After Partial Reopening of Schools in England. Pediatr Infect Dis J. 2021 06 01; 40(6):e243-e245.
Score: 0.237
-
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020. Lancet Reg Health Eur. 2021 Apr; 3:100075.
Score: 0.234
-
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers. J Infect. 2021 05; 82(5):162-169.
Score: 0.234
-
Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation. Lancet Reg Health Eur. 2021 Mar; 2:100015.
Score: 0.233
-
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England. Clin Infect Dis. 2021 03 01; 72(5):e65-e75.
Score: 0.233
-
SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July-December 2020, England. J Infect. 2021 04; 82(4):67-74.
Score: 0.233
-
Stillbirths During the COVID-19 Pandemic in England, April-June 2020. JAMA. 2021 01 05; 325(1):86-87.
Score: 0.231
-
SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England. Lancet Infect Dis. 2021 03; 21(3):344-353.
Score: 0.229
-
High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England. EClinicalMedicine. 2020 Nov; 28:100597.
Score: 0.228
-
Regular mass screening for SARS-CoV-2 infection in care homes already affected by COVID-19 outbreaks: Implications of false positive test results. J Infect. 2021 02; 82(2):282-327.
Score: 0.226
-
Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020. EClinicalMedicine. 2020 Sep; 26:100533.
Score: 0.225
-
Increased risk of SARS-CoV-2 infection in staff working across different care homes: enhanced CoVID-19 outbreak investigations in London care Homes. J Infect. 2020 Oct; 81(4):621-624.
Score: 0.224
-
Outbreaks of severe pneumococcal disease in closed settings in the conjugate vaccines era, 2010-2018: A systematic review to inform national guidance in the UK. J Infect. 2019 12; 79(6):495-502.
Score: 0.212
-
Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015. Vaccine. 2018 06 18; 36(26):3876-3881.
Score: 0.191
-
Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine. Vaccine. 2017 10 13; 35(43):5814-5818.
Score: 0.183
-
Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study. PLoS One. 2017; 12(5):e0177082.
Score: 0.179
-
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet. 2016 12 03; 388(10061):2775-2782.
Score: 0.172
-
Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England. Euro Surveill. 2021 07; 26(28).
Score: 0.060
-
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021 Jul; 22(7):928.
Score: 0.060
-
COVID-19 outbreaks following full reopening of primary and secondary schools in England: Cross-sectional national surveillance, November 2020. Lancet Reg Health Eur. 2021 Jul; 6:100120.
Score: 0.059
-
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021 05; 22(5):620-626.
Score: 0.058
-
Robust antibody responses in 70-80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021. Euro Surveill. 2021 03; 26(12).
Score: 0.058
-
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill. 2021 02; 26(5).
Score: 0.058
-
Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19: Prospective observational cohort study, England 2020. Lancet Reg Health Eur. 2021 Apr; 3:100038.
Score: 0.058
-
Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales. EClinicalMedicine. 2018 Dec; 6:42-50.
Score: 0.050
-
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017 10; 2(10):e473-e482.
Score: 0.046
-
Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak? J Infect. 2017 08; 75(2):95-103.
Score: 0.045
-
Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment. Lancet Infect Dis. 2017 07; 17(7):754-762.
Score: 0.044
-
Clinical and Molecular Epidemiology of Childhood Invasive Nontypeable Haemophilus influenzae Disease in England and Wales. Pediatr Infect Dis J. 2016 Mar; 35(3):e76-84.
Score: 0.041